Clostridioides difficile toxin testing and positivity in Manitoba, Canada.

Christiaan H RigholtGeng ZhangGregory W HammondPhilippe Lagace-WiensSalaheddin M Mahmud

Published in: Infection control and hospital epidemiology (2020)

We assessed Clostridioides difficile toxin testing and positivity for all patients in Manitoba hospitals during June 2016-November 2018. The testing rate was 30 per 10,000 patient bed days (95% confidence interval [CI], 30-31) and the incidence rate was 3.5 per 10,000 patient bed days (95% CI, 3.3-3.7). The context of testing is essential to the interpretation of data among jurisdictions.

Keyphrases

clostridium difficile
escherichia coli
end stage renal disease
case report
newly diagnosed
healthcare
chronic kidney disease
risk factors
prognostic factors
electronic health record
patient reported outcomes
machine learning
big data